Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Paclitaxel and its derivativesF1 I SEP / 98
Palbociclib or its saltsPDL I AUG / 16
PaliferminF1 I FEB / 07
Paliperidone and its salts and its derivativesF1 I MAY / 09
PalivizumabF1 I MAY / 04
Palonosetron or its saltsPDL

including but not limited to palonosetron hydrochloride

I DEC / 17
Pamidronic acid and its saltsF1 I SEP / 98
Pancreatic extractsPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancreatic extracts, pancreatin, pancrelipase except when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency U DEC / 13
PancreatinPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
PancrelipasePDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancuronium and its saltsF1 I SEP / 98
PanitumumabF1 I OCT / 09
Pantoprazole and its saltsF1 I SEP / 98
Papain as a debriding agent U SEP / 99
Papaveretrine and its salts I SEP / 98
Papaverine and its salts I SEP / 98
ParaldehydeF1 I SEP / 98
ParamethadioneF1 I SEP / 98
Pargyline and its saltsF1 I SEP / 98
ParicalcitolF1 I FEB / 07
Paritaprevir (Veruprevir)PDL I MAR / 15
ParomomycinF1 I SEP / 98
Paroxetine and its saltsF1 I SEP / 98
Paroxypropione II SEP / 98
Pazopanib or its saltsPDL I DEC / 13
Pegaptanib and its saltsF1 I FEB / 07
PegaspargasePDL I APR / 17
PegfilgrastimF1 I APR / 07
PegvisomantF1 I FEB / 07
PembrolizumabPDL I JUN / 15
Pemetrexed and its saltsF1 I APR / 07
Pemoline and any salts thereofC4 I JAN / 03
Penciclovir and its saltsF1 I MAY / 00
PenicillamineF1 I SEP / 98
Penicillin or its salts or derivativesPDL

including but not limited to amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin and ticarcillin

I DEC / 13
Pentaerythritol tetranitrate I SEP / 98
Pentagastrin and its salts II SEP / 98
Pentamidine and its saltsF1 I SEP / 98
PentazocineN I JUN / 02
PentobarbitalC1 I JUN / 02
Pentolinium tartrateF1 I SEP / 98
Pentosan polysulfate and its saltsF1 I SEP / 98
Pentostatin and its saltsF1 I SEP / 98
Pentoxifylline and its saltsF1 I SEP / 98
Pepsin U
Peptone U
Peramivir or its salts or derivativesPDL I APR / 17
PerflutrenF1 I JUL / 03
Pergolide and its saltsF1 I SEP / 98
Pericyazine and its saltsF1 I SEP / 98
Perindopril and its saltsF1 I SEP / 98
Permethrin and its derivatives II SEP / 98
Perphenazine and its saltsF1 I SEP / 98
Pertussis vaccine II DEC / 98
PethidineN I JUN / 02
Pethidine Intermediate CN I JUN / 02
Phacetoperane and its saltsF1 I SEP / 98
PhenacemideF1 I SEP / 98
PhenacetinF1 I SEP / 98
PhenadoxoneN I JUN / 02
PhenaglycodolF1 I SEP / 98
PhenampromideN I JUN / 02
PhenazocineN I JUN / 02
Phenazopyridine and its saltsF1 I SEP / 98
PhencyclidineN I JUN / 02
Phendimetrazine and any salt thereofC1 I JUN / 02
Phenelzine and its saltsF1 I SEP / 98
Phenformin and its saltsF1 I SEP / 98
Pheniprazine and its saltsF1 I SEP / 98
Pheniramine U
Phenmetrazine and any salt thereofC1 I JUN / 02
PhenobarbitalC2 I JUN / 02
Phenol preparations with concentration of more than 20% II SEP / 98
PhenomorphanN I JUN / 02
PhenoperidineN I JUN / 02
Phenoxybenzamine and its salts II SEP / 98
Phentermine and any salt thereofC2 I JUN / 02
Phenthoxate and its saltsF1 I SEP / 98
Phentolamine or its saltsPDL I DEC / 13
Phenylbutazone and its saltsF1 I SEP / 98
Phenylbutyrate sodiumPDL I MAR / 15
Phenylephrine and its saltsF1 in preparations for parenteral use or ophthalmic use in concentrations greater than 2.5% I SEP / 98
Phenylephrine and its salts and preparations in nasal preparations in concentrations of 2.5% or less, for pediatric use II SEP / 98
Phenylephrine and its salts and preparations. for oral use, in nasal preparations for adults and in ophthalmic preparations in concentrations of 2.5% or less U
Phenylindanedione and its derivativesF1 I SEP / 98
Phenylmethylbarbituric AcidC2 I JUN / 02
Phenyltoloxamine and its salts III SEP / 98
PholcodineN I JUN / 02
Physostigmine salicylateF2 except preparations for oral or topical use only I SEP / 98
Physostigmine salicylate.

for oral or topical use

II SEP / 98
Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids.*PDL

except:
1) derivatives of cannabis as defined in subsection 2(1) of the Cannabis Act that are exempt from the application of the Cannabis Act under the Industrial Hemp Regulations and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or

2) anything referred to in Schedule 2 to the Cannabis Act that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

*Note: this listing is copied from the Health Canada Prescription Drug List and applies to products that have received a Notice of Compliance and Drug Identification Number and been classified as prescription drugs by Health Canada. Cannabis products, as defined in the Cannabis Act and its regulations, are not granted a Notice of Compliance and Drug Identification Number by Health Canada and are considered outside the scope of the National Drug Schedules.

I OCT / 18
PibrentasvirPDL I SEP / 17
Pilocarpine and its saltsF1 I SEP / 98
PimecrolimusF1 I JUN / 06
PiminodineN I JUN / 02
PimobendanF1 I JUN / 08
PimozideF1 I SEP / 98
Pinaverium bromideF1 I SEP / 98
PinazepamTS I JUN / 02

208 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled